Friend or foe? ACE2 inhibitors and GLP-1R agonists in COVID-19 treatment
Juan Pang, Mingyao Liu, Wenhua Ling, Tianru Jin
Topics & Concepts
MedicineDiabetes mellitusCoronavirus disease 2019 (COVID-19)ObesityPandemicType 2 diabetesAngiotensin-converting enzyme 2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Internal medicineCoronavirusViral replicationVirusDrugPharmacologyDiseaseVirologyEndocrinologyInfectious disease (medical specialty)COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchCancer, Stress, Anesthesia, and Immune Response